Bright Peak Therapeutics
Edit

Bright Peak Therapeutics

https://brightpeaktx.com/
Last activity: 21.03.2022
Categories: ChemicalCorporateCultureDevelopmentEngineeringScienceTechnology
Bright Peak are developing a portfolio of first-in-class and best-in-class cytokines with optimized biological properties for the treatment of cancer and autoimmune diseases. Through a variety of proprietary technology platforms, Bright Peak is uniquely abled to conjugate its cytokines as payloads to antibodies, creating bespoke, novel and proprietary “Bright Peak Immunocytokines”, and to other cytokines as “duokines”. The Bright Peak Immunocytokines allow tissue- and cell-specific targeting of the cytokine payload with the added potential for significantly enhanced efficacy. One of the many advantages of our approach is its "off-the-shelf" feature. Using a pioneering site-specific ADC-like chemical conjugation technology, any therapeutic antibody at any stage of development can be conjugated with Bright Peak’s cytokine payloads of choice, eliminating the current complexities of antibody engineering and cell line development. Bright Peak’s team works with a passion for innovation and bold science. We are an international research-driven organization dedicated to discovering and developing cutting edge therapies that will make a difference in the lives of patients. We aim to create a vibrant and international corporate culture and are currently hiring in our Basel, Switzerland and Southern California locations.
Followers
1.62K
Website visits
8.9K /mo.
Mentions
3
Location: Switzerland, Basel-City, Basel
Employees: 11-50
Total raised: $107M
Founded date: 2017

Investors 1

DateNameWebsite
-RA Capital...racap.com

Funding Rounds 1

DateSeriesAmountInvestors
10.06.2021Series B$107MRA Capital...

Mentions in press and media 3

DateTitleDescription
21.03.2022Seasoned Board Members for Swiss Startups
14.06.2021Bright Peak Therapeutics Closes $107 Million Financing Round
10.06.2021Bright Peak Therapeutics Announces $107 Million Series B Financing and Expanded Board of Directors--Proceeds to advance company’s pipeline of next-generation cytokine immunotherapies-- --Laura Shawver, Christine Siu join as independent directors-- BASEL, Switzerland and SAN DIEGO, Calif., June 10, 2021 (GLOBE NEWSWIRE) -- Bright Peak Th...

Reviews 0

Sign up to leave a review

Sign up Log In